Supplements

Metabolic Health

Berberine vs Semaglutide: What the Evidence Actually Shows. Part of the Supplements library by Dr. med. univ. Julian Douwes

22 articles · 235 min total
01

5-Amino-1MQ: The NNMT Inhibitor With No Human Data

5-Amino-1MQ blocks NNMT, raising NAD+ and suppressing fat storage in mice. The rodent evidence is strong and consistent. Human trials: zero. What that means in practice.

5-Amino-1MQ: The NNMT Inhibitor With No Human Data
02

Adipotide (FTPP): Fat-Cell Ablation and the Kidney Problem

Adipotide kills the blood supply of white fat. It reversed obesity in mice and monkeys, caused dose-limiting kidney changes, and its only human trial stopped after four patients.

Adipotide (FTPP): Fat-Cell Ablation and the Kidney Problem
03

AICAR: The Exercise Mimetic That Needs Grams, Not Milligrams

AICAR activates AMPK and improved endurance in untrained mice. In humans it has been given to thousands of cardiac surgery patients — at gram doses — and failed its definitive trial.

AICAR: The Exercise Mimetic That Needs Grams, Not Milligrams
04

Native GLP-1 (7-36 Amide): Why "Pure GLP-1" Fails as a Drug

Native GLP-1 7-36 amide is the real human incretin hormone — and it lasts about two minutes in blood. What the infusion trials showed and why analogues replaced it.

Native GLP-1 (7-36 Amide): Why "Pure GLP-1" Fails as a Drug
05

HGH Fragment 176-191: The Unmodified Fragment vs AOD-9604

HGH Fragment 176-191 is sold as a fat-loss peptide and is not the same molecule as AOD-9604. What the 1978–2001 rodent work showed, the protocols people use, and the honest verdict.

HGH Fragment 176-191: The Unmodified Fragment vs AOD-9604
06

Liraglutide: The First GLP-1 for Weight Loss, Reassessed

Liraglutide (Saxenda, Victoza) was the first GLP-1 approved for obesity. What SCALE and LEADER showed, the full titration schedule, and where a daily shot still wins.

Liraglutide: The First GLP-1 for Weight Loss, Reassessed
07

Mazdutide: The GLP-1/Glucagon Dual Agonist Approved in China

Mazdutide (Xinermei, IBI362) is a GLP-1/glucagon dual agonist approved in China. GLORY-1, GLORY-2 and US phase 2 results, dosing to 9 mg, and how it differs from tirzepatide.

Mazdutide: The GLP-1/Glucagon Dual Agonist Approved in China
08

Tirzepatide: The Dual GIP/GLP-1 Agonist in Full

Tirzepatide (Mounjaro, Zepbound) in depth: 21% weight loss in SURMOUNT-1, randomised outcome data in sleep apnoea, HFpEF and MASH, the full titration schedule and the trade-offs.

Tirzepatide: The Dual GIP/GLP-1 Agonist in Full
09

Black Seed Oil (Nigella Sativa): Thymoquinone's Role in Immune Balance and Inflammation

A physician's evidence-based guide to black seed oil and thymoquinone—dosing, mechanisms, clinical uses in MCAS, autoimmunity, and metabolic health, plus who should avoid it.

Black Seed Oil (Nigella Sativa): Thymoquinone's Role in Immune Balance and Inflammation
10

Humanin Peptide Dosage Protocol: A Physician's Guide to Dosing, Timing, and Administration

Evidence-based humanin peptide dosing guide covering optimal doses, injection frequency, cycling, routes of administration, and patient-specific titration strategies.

Humanin Peptide Dosage Protocol: A Physician's Guide to Dosing, Timing, and Administration
11

Berberine Drug Interactions: What Every Patient on Berberine Needs to Know

Berberine inhibits CYP3A4 and P-gp, creating clinically significant interactions with statins, warfarin, cyclosporine, and more. A physician's evidence-based guide.

Berberine Drug Interactions: What Every Patient on Berberine Needs to Know
12

Rapamycin and Liver Health: What mTOR Inhibition Does to Hepatic Metabolism

How rapamycin targets mTOR in the liver to reverse diet-induced metabolic stress, protect hepatocytes, and what this means for longevity patients with metabolic risk.

Rapamycin and Liver Health: What mTOR Inhibition Does to Hepatic Metabolism
13

MOTS-c Peptide Dosage: A Physician's Protocol Guide

Evidence-based MOTS-c dosage guide covering subcutaneous injection protocols, cycling schedules, stacking strategies, and who benefits most from this mitochondrial peptide.

MOTS-c Peptide Dosage: A Physician's Protocol Guide
14

VK2735 Oral GLP-1 Peptide: What Patients and Clinicians Need to Know in 2026

VK2735 is a dual GIP/GLP-1 agonist from Viking Therapeutics, in Phase 3 as a weekly injection and tested in Phase 2 as a daily tablet. What the data show.

VK2735 Oral GLP-1 Peptide: What Patients and Clinicians Need to Know in 2026
15

Retatrutide vs Semaglutide vs Tirzepatide: The Triple Agonist Compared

A clinical comparison of GLP-1, dual GIP/GLP-1, and triple GIP/GLP-1/glucagon agonists — efficacy, weight loss, muscle preservation, and who qualifies in 2026.

Retatrutide vs Semaglutide vs Tirzepatide: The Triple Agonist Compared
16

Benfotiamine for Peripheral Neuropathy: A Physician's Evidence Review

Fat-soluble thiamine that crosses cell membranes conventional B1 cannot. How benfotiamine repairs peripheral nerves, reduces oxidative stress, and supports recovery in Lyme, diabetes, and post-COVID neuropathy.

Benfotiamine for Peripheral Neuropathy: A Physician's Evidence Review
17

Berberine vs Semaglutide: What the Evidence Actually Shows

A physician's evidence-based comparison of berberine and semaglutide for blood sugar control and weight loss — mechanisms, efficacy, safety, and who benefits most.

Berberine vs Semaglutide: What the Evidence Actually Shows
18

Fasting Mimicking Diet for Longevity: A Physician's Evidence Review

What the science says about the fasting mimicking diet, ProLon, autophagy, and whether a 5-day caloric restriction cycle belongs in a longevity protocol.

Fasting Mimicking Diet for Longevity: A Physician's Evidence Review
19

Continuous Glucose Monitoring: A Physician's Guide to Metabolic Health Optimization

Learn how CGM devices reveal hidden glucose patterns, guide nutrition decisions, and predict metabolic disease years before conventional labs catch it.

Continuous Glucose Monitoring: A Physician's Guide to Metabolic Health Optimization
20

Akkermansia muciniphila: The Gut Barrier Strain Your Longevity Protocol Is Missing

Akkermansia muciniphila strengthens gut barrier integrity, improves metabolic markers, and predicts immunotherapy response. A clinical review of supplementation evidence.

Akkermansia muciniphila: The Gut Barrier Strain Your Longevity Protocol Is Missing
21

MOTS-c Peptide: The Mitochondrial Signal That Reshapes Metabolism and Longevity

MOTS-c is a mitochondria-encoded peptide that activates AMPK, improves insulin sensitivity, and may extend healthspan. A physician's clinical overview.

MOTS-c Peptide: The Mitochondrial Signal That Reshapes Metabolism and Longevity
22

Berberine and Blood Sugar: Mechanisms, Evidence, and Clinical Protocols

Dr. Douwes breaks down how berberine lowers blood sugar, what the clinical trials actually show, and the dosing protocol he uses in practice.

Berberine and Blood Sugar: Mechanisms, Evidence, and Clinical Protocols
← Back to Supplements